CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,327,241 | +35.7% | 1,161,964 | -0.5% | 0.01% | +50.0% |
| Q2 2023 | $12,772,876 | +23.8% | 1,167,413 | -1.3% | 0.00% | +33.3% |
| Q1 2023 | $10,318,742 | +125097.1% | 1,183,236 | -10.0% | 0.00% | +50.0% |
| Q4 2022 | $8,242 | -99.8% | 1,314,522 | +5.4% | 0.00% | 0.0% |
| Q3 2022 | $4,366,000 | +37.3% | 1,247,365 | +15.7% | 0.00% | +100.0% |
| Q2 2022 | $3,179,000 | +8.6% | 1,077,686 | +14.5% | 0.00% | 0.0% |
| Q1 2022 | $2,926,000 | +8.9% | 940,806 | +18.4% | 0.00% | 0.0% |
| Q4 2021 | $2,686,000 | -5.4% | 794,841 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $2,840,000 | -43.9% | 778,115 | -33.0% | 0.00% | -50.0% |
| Q2 2021 | $5,063,000 | -15.6% | 1,161,109 | -12.2% | 0.00% | 0.0% |
| Q1 2021 | $6,002,000 | -16.5% | 1,322,192 | +5.6% | 0.00% | -33.3% |
| Q4 2020 | $7,187,000 | -5.0% | 1,251,986 | +19.8% | 0.00% | 0.0% |
| Q3 2020 | $7,563,000 | +138.1% | 1,044,735 | +14.8% | 0.00% | +200.0% |
| Q2 2020 | $3,177,000 | +102.6% | 910,303 | -14.1% | 0.00% | 0.0% |
| Q1 2020 | $1,568,000 | -26.9% | 1,059,531 | -3.1% | 0.00% | 0.0% |
| Q4 2019 | $2,144,000 | -63.4% | 1,093,885 | -4.4% | 0.00% | -50.0% |
| Q3 2019 | $5,860,000 | -26.6% | 1,144,516 | +2.6% | 0.00% | -33.3% |
| Q2 2019 | $7,989,000 | -42.8% | 1,115,859 | +6.1% | 0.00% | -50.0% |
| Q1 2019 | $13,971,000 | +147.6% | 1,052,066 | +46.7% | 0.01% | +100.0% |
| Q4 2018 | $5,643,000 | +47.2% | 716,974 | +107.2% | 0.00% | +200.0% |
| Q3 2018 | $3,834,000 | – | 345,989 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,629,464 | $14,208,926 | 10.61% |
| Lynx1 Capital Management LP | 1,369,927 | $11,945,763 | 9.96% |
| Versant Venture Management, LLC | 543,753 | $4,741,526 | 9.88% |
| Foresite Capital Management IV, LLC | 1,787,094 | $15,583,460 | 8.09% |
| Octagon Capital Advisors LP | 4,570,918 | $39,858,405 | 5.74% |
| ACUTA CAPITAL PARTNERS, LLC | 878,500 | $7,660,520 | 5.64% |
| TCG Crossover Management, LLC | 3,048,257 | $26,580,801 | 5.18% |
| Affinity Asset Advisors, LLC | 1,083,118 | $9,444,789 | 3.12% |
| Altium Capital Management LP | 620,000 | $5,406,400 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 2,500,000 | $21,800 | 2.72% |